buspirone has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies
Buspirone: An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
buspirone : An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.
Non-alcoholic Fatty Liver Disease: Fatty liver finding without excessive ALCOHOL CONSUMPTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nonalcoholic fatty liver disease (NAFLD) is increasingly prevalent worldwide, causing serious liver complications, including nonalcoholic steatohepatitis." | 1.56 | Design, Synthesis, and Biological Evaluation of New Peripheral 5HT ( Ahn, JH; Bae, MA; Choi, W; Choi, WG; Hwang, I; Jeon, JH; Kim, D; Kim, H; Kim, M; Kim, MJ; Lee, EY; Lee, H; Lee, IK; Lee, SM; Lee, WM; Pagire, HS; Pagire, SH; Song, JS; Yoo, EK; Yoon, J, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, M | 1 |
| Hwang, I | 1 |
| Pagire, HS | 1 |
| Pagire, SH | 1 |
| Choi, W | 1 |
| Choi, WG | 1 |
| Yoon, J | 1 |
| Lee, WM | 1 |
| Song, JS | 1 |
| Yoo, EK | 1 |
| Lee, SM | 1 |
| Kim, MJ | 1 |
| Bae, MA | 1 |
| Kim, D | 1 |
| Lee, H | 1 |
| Lee, EY | 1 |
| Jeon, JH | 1 |
| Lee, IK | 1 |
| Kim, H | 1 |
| Ahn, JH | 1 |
1 other study available for buspirone and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Design, Synthesis, and Biological Evaluation of New Peripheral 5HT
Topics: Animals; Diet, High-Fat; Drug Design; Drug Evaluation, Preclinical; HEK293 Cells; Humans; Male; Mice | 2020 |